Home › Funds › Arrowstreet Capital › DBD
Arrowstreet Capital position in DBD
DIEBOLD NIXDORF INC · Miscellaneous
Latest position (Q2 2026)468.04K sh
Reported value held$39.79M
Portfolio Weight0.02%
First reportedQ1 2024
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 33.06K | $1.14K | New |
| Q2 2025 | 72.08K | $3.99M | New |
| Q3 2025 | 402.60K | $22.96M | Add |
| Q4 2025 | 430.67K | $29.24M | Add |
| Q1 2026 | 519.20K | $39.17M | Add |
| Q2 2026 | 468.04K | $39.79M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding DBD
- Capital World Investors 11.55M sh · $982.16M · Q2 2026
- BlackRock Inc 4.55M sh · $387.22M · Q2 2026
- Vanguard Group 1.96M sh · $133.03M · Q4 2025
- Geode Capital Management 842.28K sh · $71.63M · Q2 2026
- Charles Schwab Investment Management 355.33K sh · $30.21M · Q2 2026
- Morgan Stanley 303.95K sh · $25.84M · Q2 2026
- Fidelity Management & Research (FMR) 272.70K sh · $23.19M · Q2 2026
- Northern Trust Corp 270.99K sh · $23.04M · Q2 2026
- UBS Group AG 196.07K sh · $16.67M · Q2 2026
- Principal Global Investors 195.69K sh · $16.64M · Q2 2026
- Invesco Ltd 194.54K sh · $16.54M · Q2 2026